Results 11 to 20 of about 437,313 (161)

Migraine during COVID-19: Data from Second Wave Pandemic in an Italian Cohort

Brain Sciences, 2021
Objectives: The study aims to assess the impact of the second COVID-19 pandemic wave on migraine characteristics. Methods: This is an observational cross-sectional study conducted on migraine patients previously interviewed during the first Italian ...
Eleonora Gentile, Marianna Delussi, Chiara Abagnale, Valeria Caponnetto, Francesco De Cesaris, Ilaria Frattale, Elena Guaschino, Andrea Marcinnò, Raffaele Ornello, Francesca Pistoia, Alessia Putortì, Giusy Candida, Fausto Roveta, Chiara Lupi, Gianluca Coppola, Addolorata Maria Pia Prudenzano, Innocenzo Rainero, Grazia Sances, Maria Elena Roca, Maria Trojano, Francesco Pierelli, Pierangelo Geppetti, Simona Sacco, Marina de Tommaso   +23 more
doaj   +1 more source

Myofascial trigger points in migraine and tension-type headache

The Journal of Headache and Pain, 2018
Background A myofascial trigger point is defined as a hyperirritable spot in skeletal muscle that is associated with a hypersensitive palpable nodule in a taut band.
Thien Phu Do, Gerda Ferja Heldarskard, Lærke Tørring Kolding, Jeppe Hvedstrup, Henrik Winther Schytz   +4 more
doaj   +1 more source

Patients and general practitioners assessment of the main outcomes employed in the acute and preventive treatment of migraine: a cross sectional study

BMC Neurology, 2021
Background We aim to describe and compare patients and general practitioners’ opinions about the different variables related to acute and preventive treatment for migraine. Patients and methods An observational descriptive study was performed.
Javier Trigo-López, Ángel Luis Guerrero-Peral, Álvaro Sierra, Enrique Martínez-Pías, María Gutiérrez-Sánchez, Elizabeth Huzzey, David García-Azorín   +6 more
doaj   +1 more source

Searching for the Predictors of Response to BoNT-A in Migraine Using Machine Learning Approaches

Toxins, 2023
OnabotulinumtoxinA (BonT-A) reduces migraine frequency in a considerable portion of patients with migraine. So far, predictive characteristics of response are lacking. Here, we applied machine learning (ML) algorithms to identify clinical characteristics
Daniele Martinelli, Maria Magdalena Pocora, Roberto De Icco, Marta Allena, Gloria Vaghi, Grazia Sances, Gloria Castellazzi, Cristina Tassorelli   +7 more
doaj   +1 more source

Menstrual migraine is caused by estrogen withdrawal: revisiting the evidence

The Journal of Headache and Pain, 2023
Objective To explore and critically appraise the evidence supporting the role of estrogen withdrawal in menstrual migraine. Main body Menstrual migraine, impacting about 6% of reproductive-age women, manifests as migraine attacks closely related to the ...
Bianca Raffaelli, Thien Phu Do, Basit Ali Chaudhry, Messoud Ashina, Faisal Mohammad Amin, Håkan Ashina   +5 more
doaj   +1 more source

Prolonged migraine aura: new insights from a prospective diary-aided study

The Journal of Headache and Pain, 2018
Background There is limited literature on prolonged aura (PA - defined as an aura including at least one symptom for > 1 h and  4 h (n = 14) with the the others (n = 193 and n = 202 respectively). Conclusion PAs are quite common.
Michele Viana, Grazia Sances, Mattias Linde, Giuseppe Nappi, Farihah Khaliq, Peter J. Goadsby, Cristina Tassorelli   +6 more
doaj   +1 more source

Medication-overuse headache—a review of different treatment strategies

Frontiers in Pain Research, 2023
Medication-overuse headache (MOH) can develop from primary headaches. MOH is usually the result of overuse of symptomatic medications. It is a noteworthy personal and societal burden.
Abouch Krymchantowski, Carla Jevoux, Ana Gabriela Krymchantowski, Luiza Barbosa Ramos, Jackeline S. S. Barbosa, Raimundo Pereira Silva-Neto   +5 more
doaj   +1 more source

Occipital Nerve Stimulation in Chronic Migraine: The Relationship Between Perceived Sensory Quality, Perceived Sensory Location, and Clinical Efficacy—A Prospective, Observational, Non-Interventional Study

Pain and Therapy, 2020
Introduction Occipital nerve stimulation (ONS) is used to treat therapy-resistant chronic migraine. Clinical use has resulted in a wide intraindividual and interindividual variation of clinical efficacy.
Carl H. Göbel, Anna Göbel, Uwe Niederberger, Axel Heinze, Katja Heinze-Kuhn, Christoph Meinecke, Hubertus M. Mehdorn, Dirk Rasche, Hartmut Göbel   +8 more
doaj   +1 more source

In search of a gold standard patient-reported outcome measure to use in the evaluation and treatment-decision making in migraine prevention. A real-world evidence study

The Journal of Headache and Pain, 2021
Background Patient-Reported Outcomes (PROs) have been developed to numerically quantify disability, impact and quality of life. They have been widely used in migraine clinical trials.
Alicia Alpuente, Victor J Gallardo, Edoardo Caronna, Marta Torres-Ferrus, Patricia Pozo-Rosich   +4 more
doaj   +1 more source

Clinical characteristics of nummular headache and differentiation between spontaneous and posttraumatic variant: an observational study

The Journal of Headache and Pain, 2019
Background Head trauma has been described as a precipitating event in Nummular Headache (NH). We aimed to describe the largest NH published series and compare characteristics between idiopathic and post-traumatic cases.
Javier Trigo, David García-Azorín, Enrique Martinez Pias, Álvaro Sierra, Alba Chavarría, Angel Luis Guerrero   +5 more
doaj   +1 more source